EuroEvents is pleased to invite you to the inaugural edition of the Compliance and Transparency Conference for Life sciences, on 26th and 27th of September 2019 in Amsterdam, The Netherlands.
As a heavy regulated industry, the companies are facing ever-changing regulatory requirements. Having this in mind, EuroEvents through the CTELS conference offers a platform for open discussion and exchange of best practices between the industry peers on some of the present-day challenges and strategies compliance professionals face across the life sciences industry.
Industry best professionals will share their knowledge and experience on the latest updates on the regulatory landscape. Moreover the conference will offer presentations and discussions on latest trends and practices in various specific aspects and components of effective compliance and transparency programs. The trending topic of culture of integrity as a valuable corporate asset will be addressed with presentation and discussion, focusing on value-driven and control-based compliance. In the conference, you can also hear about how the tech-giants and startups are affecting the market. The speakers will discuss the challenges of emerging technologies and the possibilities but also the challenges that emerge – among with the competitive landscape. Last but not least, social media as one of the most important modern tools is going to be dealt with it being as a rising compliance issue in managing a patient-centric ecosystem,
The conference will bring you close to speakers and professionals that work in the industry for 15+ years, variety of backgrounds and areas covered with some of the speakers being: Daniel Schafaghi (Boehringer-Ingelheim), Detlef Geiges (Astra Zeneca), Natacha Udo-Beauvisage,(Servier), Martine Zimmermann (Alexion Pharma), Aleksej Daineko (LEO Pharma), Ariadna Quesada (Hillrom) and Liesbeth Bergmans (Teva Pharmaceuticals). Diversity matters to discover new risk areas and different country laws and practices.
You will have the opportunity to connect with distinguished colleagues armed with enforcement revelations and knowledge of emerging risk areas, substantial to tackle the industry’s most pressing challenges.
Join us in a very new home of the European Medicines Agency for a remarkable experience!
Reserve your seat right now here